Trademark: 87305763
Status Date
Tuesday, August 25, 2020
Registration Number
6136578
Registration Date
Tuesday, August 25, 2020
Filing Date
Wednesday, January 18, 2017
Published for Opposition
Tuesday, November 28, 2017
5 Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals(Based on 44(e)) Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
42 Conducting early evaluations in the field of new pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research on the subject of pharmaceuticals
The English translation of "TOWA" in the mark is "FOREVER".
"PHARMACEUTICAL"
Apr 20, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 20, 2022
Teas Change Of Correspondence Received
Apr 20, 2022
Teas Change Of Domestic Representatives Address
Apr 20, 2022
Teas Withdrawal Of Attorney Received-Firm Retains
Apr 20, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 20, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 20, 2022
Teas Change Of Owner Address Received
Aug 25, 2020
Registered-Principal Register
Jul 20, 2020
Amendment/Petition After Approval For Pub Entered
Jul 18, 2020
Notice Of Acceptance Of Statement Of Use E-Mailed
Jul 17, 2020
Allowed Principal Register - Sou Accepted
Jul 16, 2020
Notice Of Revival - E-Mailed
Jul 16, 2020
Petition Granted - Response Received
Jul 8, 2020
Assigned To Petition Staff
May 11, 2020
Teas Response To Office Action Received
May 11, 2020
Teas Petition To Revive Received
May 4, 2020
Teas Change Of Correspondence Received
May 4, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
May 4, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
May 4, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 1, 2020
Abandonment Notice E-Mailed - Failure To Respond
Apr 1, 2020
Abandonment - Failure To Respond Or Late Response
Sep 17, 2019
Notification Of Final Refusal Emailed
Sep 17, 2019
Final Refusal E-Mailed
Sep 17, 2019
Su - Final Refusal - Written
Sep 3, 2019
Teas/Email Correspondence Entered
Sep 3, 2019
Correspondence Received In Law Office
Aug 29, 2019
Assigned To Lie
Aug 23, 2019
Teas Response To Office Action Received
May 24, 2019
Notification Of Non-Final Action E-Mailed
May 24, 2019
Non-Final Action E-Mailed
May 24, 2019
Su - Non-Final Action - Written
May 24, 2019
Previous Allowance Count Withdrawn
May 17, 2019
On Hold - Electronic Record Review Required
May 16, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
May 15, 2019
Electronic Record Review Complete
May 10, 2019
On Hold - Electronic Record Review Required
May 7, 2019
Notice Of Approval Of Extension Request E-Mailed
May 7, 2019
Notice Of Acceptance Of Statement Of Use E-Mailed
May 6, 2019
Allowed Principal Register - Sou Accepted
May 5, 2019
Statement Of Use Processing Complete
Apr 23, 2019
Use Amendment Filed
May 5, 2019
Sou Extension 2 Granted
Jan 23, 2019
Sou Extension 2 Filed
May 5, 2019
Case Assigned To Intent To Use Paralegal
Apr 23, 2019
Teas Statement Of Use Received
Apr 24, 2019
Notice Of Revival - E-Mailed
Apr 23, 2019
Extension Received With Teas Petition
Apr 23, 2019
Petition To Revive-Granted
Apr 23, 2019
Teas Petition To Revive Received
Feb 25, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 25, 2019
Abandonment - No Use Statement Filed
Jul 24, 2018
Notice Of Approval Of Extension Request E-Mailed
Jul 22, 2018
Sou Extension 1 Granted
Jul 22, 2018
Sou Extension 1 Filed
Jul 22, 2018
Teas Extension Received
Jan 23, 2018
Noa E-Mailed - Sou Required From Applicant
Nov 28, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 28, 2017
Published For Opposition
Nov 8, 2017
Notification Of Notice Of Publication E-Mailed
Oct 19, 2017
Approved For Pub - Principal Register
Oct 17, 2017
Teas/Email Correspondence Entered
Oct 17, 2017
Correspondence Received In Law Office
Oct 17, 2017
Teas Response To Office Action Received
Apr 18, 2017
Notification Of Non-Final Action E-Mailed
Apr 18, 2017
Non-Final Action E-Mailed
Apr 18, 2017
Non-Final Action Written
Apr 13, 2017
Assigned To Examiner
Jan 25, 2017
New Application Office Supplied Data Entered In Tram
Jan 21, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
